March 2021

Issue highlights:

  • News:
    • FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies
    • Fujifilm plans to use the therapeutic cGMP-compliant iPSC manufacturing facility of FUJIFILM Cellular Dynamics, Inc. to expand the contract development and manufacturing of the therapeutic.
  • Events:
    • Register now for the AXXAM Bootcamp Webinar: Riding the Calcium Wave on iCell GlutaNeurons During HTS
  • Publications:
    • hiPSC-Derived Neurons Provide a Robust and Physiologically Relevant In Vitro Platform to Test Botulinum Neurotoxins
    • Relationships Between Constituents of Energy Drinks and Beating Parameters in Human Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes
    • High-Content Analysis and Kinetic Image Cytometry Identify Toxic and Epigenotoxic Effects of HIV Antiretrovirals on Human iPSC-Neurons and Primary Neural Precursor Cells
    • Assessing the Angiogenic Efficacy of Pleiotrophin Released from Injectable Heparin-Alginate Gels